Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195


Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection.

Sasson SC, Zaunders JJ, Zanetti G, King EM, Merlin KM, Smith DE, Stanley KK, Cooper DA, Kelleher AD.

J Infect Dis. 2006 Feb 15;193(4):505-14. Epub 2006 Jan 17.


IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

Sasson SC, Smith S, Seddiki N, Zaunders JJ, Bryant A, Koelsch KK, Weatherall C, Munier ML, McGinley C, Yeung J, Mulligan SP, Moore J, Cooper DA, Milliken S, Kelleher AD.

Cytokine. 2010 Apr;50(1):58-68. doi: 10.1016/j.cyto.2009.12.001. Epub 2010 Jan 8.


Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy.

Read SW, Higgins J, Metcalf JA, Stevens RA, Rupert A, Nason MC, Lane HC, Sereti I.

J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):537-44.


Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients.

Rethi B, Fluur C, Atlas A, Krzyzowska M, Mowafi F, Grützmeier S, De Milito A, Bellocco R, Falk KI, Rajnavölgyi E, Chiodi F.

AIDS. 2005 Dec 2;19(18):2077-86.


Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.

Mercier F, Boulassel MR, Yassine-Diab B, Tremblay C, Bernard NF, Sekaly RP, Routy JP.

Clin Exp Immunol. 2008 Apr;152(1):72-80. doi: 10.1111/j.1365-2249.2008.03610.x. Epub 2008 Feb 14.


Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.

Zaunders JJ, Ip S, Munier ML, Kaufmann DE, Suzuki K, Brereton C, Sasson SC, Seddiki N, Koelsch K, Landay A, Grey P, Finlayson R, Kaldor J, Rosenberg ES, Walker BD, Fazekas de St Groth B, Cooper DA, Kelleher AD.

J Virol. 2006 Oct;80(20):10162-72.


Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.

Beq S, Bugault F, Colle JH, Lambotte O, Delfraissy JF, Thèze J.

Eur Cytokine Netw. 2005 Dec;16(4):293-9.


Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.

Paiardini M, Cervasi B, Albrecht H, Muthukumar A, Dunham R, Gordon S, Radziewicz H, Piedimonte G, Magnani M, Montroni M, Kaech SM, Weintrob A, Altman JD, Sodora DL, Feinberg MB, Silvestri G.

J Immunol. 2005 Mar 1;174(5):2900-9.


IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.

Faller E, Kakal J, Kumar R, Macpherson P.

Int Immunol. 2009 Mar;21(3):203-16. doi: 10.1093/intimm/dxn140. Epub 2009 Jan 15.


Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection.

Zhang SY, Zhang Z, Fu JL, Kang FB, Xu XS, Nie WM, Zhou CB, Zhao M, Wang FS.

Eur J Immunol. 2009 May;39(5):1425-34. doi: 10.1002/eji.200839059.


HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis.

Marchetti G, Riva A, Cesari M, Bellistrì GM, Gianelli E, Casabianca A, Orlandi C, Magnani M, Meroni L, d'Arminio Monforte A, Mussini C, Cossarizza A, Galli M, Gori A; Elvis Study Group.

HIV Med. 2009 Aug;10(7):422-31. doi: 10.1111/j.1468-1293.2009.00710.x. Epub 2009 May 5.


Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.

Lécuroux C, Girault I, Boutboul F, Urrutia A, Goujard C, Meyer L, Lambotte O, Chaix ML, Martinez V, Autran B, Sinet M, Venet A; ANRS PRIMO Cohort, ANRS HIC Study Group; ANRS ALT Cohort; ANRS HIC Study Group.

AIDS. 2009 Aug 24;23(13):1649-58. doi: 10.1097/QAD.0b013e32832e6634.


CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation.

Pahwa R, McCloskey TW, Aroniadis OC, Strbo N, Krishnan S, Pahwa S.

J Infect Dis. 2006 Mar 15;193(6):879-87. Epub 2006 Feb 9.


Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy.

Mussini C, Pinti M, Borghi V, Nasi M, Amorico G, Monterastelli E, Moretti L, Troiano L, Esposito R, Cossarizza A.

AIDS. 2002 Aug 16;16(12):1609-16.


IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.

Vranjkovic A, Crawley AM, Patey A, Angel JB.

J Leukoc Biol. 2011 Apr;89(4):499-506. doi: 10.1189/jlb.0710430. Epub 2010 Dec 21.


IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells.

Vranjkovic A, Crawley AM, Gee K, Kumar A, Angel JB.

Int Immunol. 2007 Dec;19(12):1329-39. Epub 2007 Oct 22.


Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells.

Sereti I, Martinez-Wilson H, Metcalf JA, Baseler MW, Hallahan CW, Hahn B, Hengel RL, Davey RT, Kovacs JA, Lane HC.

Blood. 2002 Sep 15;100(6):2159-67.


Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients--effects of antiretroviral therapy.

Colle JH, Moreau JL, Fontanet A, Lambotte O, Joussemet M, Jacod S, Delfraissy JF, Thèze J.

J Acquir Immune Defic Syndr. 2006 Jul;42(3):277-85.


Interleukin-7 receptor expression on CD8 T-cells is downregulated by the HIV Tat protein.

Faller EM, McVey MJ, Kakal JA, MacPherson PA.

J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):257-69.

Items per page

Supplemental Content

Write to the Help Desk